About this Healthcare list
Names rising to the top of the screen
The strongest names stay in view, with the valuation context behind the ranking.
| # | Ticker | Company | MoonshotScore | Price | Change | Market Cap | P/E |
|---|---|---|---|---|---|---|---|
| 1 | BMY | Bristol-Myers Squibb Company | 85 | $58.80 | +0.79% | $120.0B | 13.01 |
| 2 | COR | Cencora, Inc. | 86 | $339.09 | -0.63% | $64.7B | 18.85 |
| 3 | CI | Cigna Corporation | 78 | $270.90 | -0.78% | $71.4B | 11.92 |
| 4 | ILMN | Illumina, Inc. | 84 | $192.82 | -3.90% | $29.2B | 32.74 |
| 5 | BSX | Boston Scientific Corporation | 77 | $41.98 | -2.35% | $60.9B | 17.71 |
| 6 | JNJ | Johnson & Johnson | 83 | $270.47 | +1.25% | $651.0B | 41.01 |
| 7 | AMGN | Amgen Inc. | 84 | $435.64 | -0.15% | $236.0B | 25.07 |
| 8 | LLY | Eli Lilly and Company | 98 | $1347.11 | -0.30% | $1.3T | 43.61 |
| 9 | MCK | McKesson Corporation | 92 | $1069.43 | +0.68% | $123.0B | 27.39 |
| 10 | DXCM | DexCom, Inc. | 93 | $79.32 | -1.08% | $29.6B | 30.63 |
| 11 | HCA | HCA Healthcare, Inc. | 77 | $475.57 | +3.31% | $99.3B | 15.71 |
| 12 | LH | Labcorp Holdings Inc. | 71 | $367.13 | -0.47% | $29.8B | 29.92 |
| 13 | DGX | Quest Diagnostics Incorporated | 74 | $258.28 | -0.31% | $28.4B | 25.37 |
| 14 | ZTS | Zoetis Inc. | 87 | $79.11 | -2.08% | $32.1B | 13.10 |
| 15 | ISRG | Intuitive Surgical, Inc. | 94 | $399.05 | -2.01% | $138.0B | 47.73 |
| 16 | IDXX | IDEXX Laboratories, Inc. | 96 | $676.21 | -1.95% | $53.3B | 45.35 |
| 17 | RMD | ResMed Inc. | 95 | $235.63 | -0.53% | $33.1B | 21.40 |
| 18 | VRTX | Vertex Pharmaceuticals Incorporated | 90 | $515.02 | -1.08% | $131.0B | 32.89 |
| 19 | CAH | Cardinal Health, Inc. | 88 | $272.81 | +0.17% | $63.1B | 35.20 |
| 20 | GEHC | GE HealthCare Technologies Inc. | 74 | $80.64 | -1.53% | $36.5B | 17.01 |
| 21 | SYK | Stryker Corporation | 80 | $310.00 | -0.98% | $118.0B | 32.80 |
Where valuation pressure is clustering
Share of the 21 listed stocks by sector (snapshot 2026-11-18).
What the numbers show
- BMY (Bristol-Myers Squibb Company) ranks first on this list, ranked by PEG ratio.
- 21 of the 21 stocks listed have a MoonshotScore of 70 or higher.
- By MoonshotScore band: 15 Exceptional (80-100), 6 Strong (65-79).
- LLY (Eli Lilly and Company) has the highest MoonshotScore on the list: 98 (Exceptional).
- When the list was built (2026-11-18), the median market cap of the 21 stocks with a reported market cap was $66.9B; the largest was LLY at $1.3T.
- 21 of the 21 stocks have a positive trailing P/E; the median among them is 26.6.
- PEG ratios on this list range from 0.05 to 3.96.
Disclaimer
“MoonshotScore rates a US-listed stock 0 to 100 using five sector-relative pillars. Higher means stronger numbers across business quality, safety, valuation, growth and momentum. Eligible common stocks and ADRs only; funds, ETFs, warrants, units, SPACs, preferreds, and notes carry none. It is built for education and deeper due diligence, not financial advice.”
Questions worth resolving before acting on the screen
How many Healthcare stocks are on this list?
21 US-listed Healthcare stocks as of 2026-11-18, out of 48 that passed the sector screen.
Which Healthcare stock ranks first on this list?
BMY (Bristol-Myers Squibb Company) ranks first, ranked by PEG ratio. Its MoonshotScore is 85 (Exceptional).
How many stocks on this list have a MoonshotScore of 70 or higher?
21 of the 21 stocks listed have a MoonshotScore of 70 or higher.
Which stock on this list has the largest market cap?
LLY (Eli Lilly and Company), at $1.3T as of 2026-11-18.
How is this list ordered?
It is ordered by PEG ratio, lowest first, after requiring a PEG ratio above 0 and below 5. The MoonshotScore is shown for reference and is not the sort key.
When was this list last updated?
The list was built from FMP data as of 2026-11-18; MoonshotScores as of 2026-11-18. The table's price, day change and market-cap columns show the latest FMP quote when one is available, dated in the table caption.